# The Impact of Covid-19 Hospital Care on the Prevalence of MDRO in Indonesia

> **NCT05293483** · — · UNKNOWN · sponsor: **Erasmus Medical Center** · enrollment: 1110 (estimated)

## Conditions studied

- Antibiotic Resistant Infection
- COVID-19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05293483
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-07
- **Primary completion:** 2022-12-07
- **Final completion:** 2023-03-07
- **Target enrollment:** 1110 (ESTIMATED)
- **Last updated:** 2022-03-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05293483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05293483, "The Impact of Covid-19 Hospital Care on the Prevalence of MDRO in Indonesia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05293483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*